What does BEAURAING MEDICAL do?

BEAURAING MEDICAL is a research organisation in Beauraing. Private Limited, started on 9 April 2003.

What is the address of BEAURAING MEDICAL?

The registered office of BEAURAING MEDICAL is located at Rue de Dinant 127, 5570 Beauraing.

Is BEAURAING MEDICAL still active?

Yes. According to the CBE (31 October 2026) BEAURAING MEDICAL is active, legal situation “Normale toestand”, started on 9 April 2003.

Is BEAURAING MEDICAL registered on Peppol?

Yes, BEAURAING MEDICAL is registered on the Peppol network with ID 0208:0479984110.

What is the enterprise number of BEAURAING MEDICAL?

The enterprise number of BEAURAING MEDICAL is BE0479984110.

When was BEAURAING MEDICAL founded?

BEAURAING MEDICAL was founded on 9 April 2003.

Who are the directors of BEAURAING MEDICAL?

According to the 2025 annual accounts, the directors of BEAURAING MEDICAL are: ETIENNE BAIJOT.

Is BEAURAING MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 April 2003; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did BEAURAING MEDICAL make in 2025?

BEAURAING MEDICAL posted a profit after taxes of € 184,131 in financial year 2025.

What is the revenue of BEAURAING MEDICAL?

As a small company, BEAURAING MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 259,573.

BEAURAING MEDICAL (Private Limited) - Beauraing

Dossier BEAURAING MEDICAL, printed on 1 November 2026 from databakkes.be/en/0479984110/beauraing-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BEAURAING MEDICAL from Beauraing, company number BE0479984110, closed financial year 2025 with a result of € 184,131 after tax. For that financial year BEAURAING MEDICAL recorded a gross margin of € 259,573 and equity of € 887,457. Compared with financial year 2024, the result moved from € 185,085 to € 184,131. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 19, 2026.

What it is worth Growing

€ 887,457

▲ 26% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 184,131

▼ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 112,030

▼ 51% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 875,057.

People and assets in 2025

Wage cost

€ 1,015

▼ 25% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 15,738

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,929

▲ 100% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 65,717

▼ 30% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 39,786 Gross margin 2022: € 39,786 First fiscal year in the series	€ 233,366 Gross margin 2023: € 233,366 ▲ € 193,580 vs 2022 (€ 39,786) Favourable step	€ 277,556 Gross margin 2024: € 277,556 ▲ 19% vs 2023 (€ 233,366) Favourable step	€ 259,573 Gross margin 2025: € 259,573 ▼ 6% vs 2024 (€ 277,556) Unfavourable step	▼ 6%
Profit after taxes	€ -7,809 Profit after taxes 2022: € -7,809 First fiscal year in the series	€ 164,853 Profit after taxes 2023: € 164,853 ▲ € 172,662 vs 2022 (€ -7,809) Favourable step	€ 185,085 Profit after taxes 2024: € 185,085 ▲ 12% vs 2023 (€ 164,853) Favourable step	€ 184,131 Profit after taxes 2025: € 184,131 ▼ 1% vs 2024 (€ 185,085) Unfavourable step	▼ 1%
Equity	€ 353,388 Equity 2022: € 353,388 First fiscal year in the series	€ 518,240 Equity 2023: € 518,240 ▲ 47% vs 2022 (€ 353,388) Favourable step	€ 703,326 Equity 2024: € 703,326 ▲ 36% vs 2023 (€ 518,240) Favourable step	€ 887,457 Equity 2025: € 887,457 ▲ 26% vs 2024 (€ 703,326) Favourable step	▲ 26%
Total debts	€ 93,989 Total debts 2022: € 93,989 First fiscal year in the series	€ 89,136 Total debts 2023: € 89,136 ▼ 5% vs 2022 (€ 93,989) Favourable step	€ 115,427 Total debts 2024: € 115,427 ▲ 29% vs 2023 (€ 89,136) Unfavourable step	€ 90,077 Total debts 2025: € 90,077 ▼ 22% vs 2024 (€ 115,427) Favourable step	▼ 22%
Cash	€ 35,234 Cash 2022: € 35,234 First fiscal year in the series	€ 51,245 Cash 2023: € 51,245 ▲ 45% vs 2022 (€ 35,234) Favourable step	€ 226,660 Cash 2024: € 226,660 ▲ € 175,415 vs 2023 (€ 51,245) Favourable step	€ 112,030 Cash 2025: € 112,030 ▼ 51% vs 2024 (€ 226,660) Unfavourable step	▼ 51%
Land & buildings	€ 2,353 Land & buildings 2022: € 2,353 First fiscal year in the series	€ 1,287 Land & buildings 2023: € 1,287 ▼ 45% vs 2022 (€ 2,353) Unchanged	€ 858 Land & buildings 2024: € 858 ▼ 33% vs 2023 (€ 1,287) Unchanged	€ 429 Land & buildings 2025: € 429 ▼ 50% vs 2024 (€ 858) Unchanged	▼ 50%
Retained profit	€ 340,988 Retained profit 2022: € 340,988 First fiscal year in the series	€ 505,840 Retained profit 2023: € 505,840 ▲ 48% vs 2022 (€ 340,988) Favourable step	€ 690,926 Retained profit 2024: € 690,926 ▲ 37% vs 2023 (€ 505,840) Favourable step	€ 875,057 Retained profit 2025: € 875,057 ▲ 27% vs 2024 (€ 690,926) Favourable step	▲ 27%
Bank debt	€ 13,341 Bank debt 2022: € 13,341 First fiscal year in the series	€ 6,099 Bank debt 2023: € 6,099 ▼ 54% vs 2022 (€ 13,341) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 6,099) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 447,377 Balance sheet total 2022: € 447,377 First fiscal year in the series	€ 607,377 Balance sheet total 2023: € 607,377 ▲ 36% vs 2022 (€ 447,377) Unchanged	€ 818,753 Balance sheet total 2024: € 818,753 ▲ 35% vs 2023 (€ 607,377) Unchanged	€ 977,534 Balance sheet total 2025: € 977,534 ▲ 19% vs 2024 (€ 818,753) Unchanged	▲ 19%

Key figures of BEAURAING MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BEAURAING MEDICAL?

What happened at BEAURAING MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 19, 2026 New annual accounts for financial year 2025: profit of € 184,131 (▼ 1% vs 2024). Source: NBB ↗
Apr 9, 2003 Start of the company according to the CBE. KBO

In short

From € 7,809 loss in 2022 to € 184,131 profit in 2025.

Paid € 254,813 in corporate taxes since 2022.

Best year ever: 2024, with € 185,085 profit.

Original PDFs at the National Bank ↗

Management

ETIENNE BAIJOT

BEAURAING MEDICAL

Behind BEAURAING MEDICAL is ETIENNE BAIJOT.

Directors

According to the 2025 annual accounts

ETIENNE BAIJOT

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Dinant 127

5570 Beauraing

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.984.110
VAT number: BE 0479.984.110
Registered office: Rue de Dinant 127, 5570 Beauraing
Names & denominations: BEAURAING MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 April 2003
Peppol: Active · Active since 11 Dec 2025
Activities · NACE: Speur- en ontwikkelingswerk op biotechnologisch gebied

View on CBE Public ↗ Annual accounts (NBB) ↗